UPDATE 2-Edwards raises outlook, plans for valve label expansion

April 26 (Reuters) - Edwards Lifesciences Corp on Tuesday raised its full-year sales and profit outlook following strong first-quarter results and said approval for expanded use of its minimally invasive heart valve implant could come sooner than previously expected.